137 related articles for article (PubMed ID: 35737160)
1. The Level of LINE-1 mRNA Is Increased in Extracellular Circulating Plasma RNA in Patients with Colorectal Cancer.
Filipenko ML; Boyarskikh UA; Leskov LS; Subbotina KV; Khrapov EA; Sokolov AV; Stilidi IS; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):261-264. PubMed ID: 35737160
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
3. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
Lin EH; Hassan M; Li Y; Zhao H; Nooka A; Sorenson E; Xie K; Champlin R; Wu X; Li D
Cancer; 2007 Aug; 110(3):534-42. PubMed ID: 17594720
[TBL] [Abstract][Full Text] [Related]
5. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer.
Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF
Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965
[TBL] [Abstract][Full Text] [Related]
6. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
[TBL] [Abstract][Full Text] [Related]
7. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.
Douard R; Moutereau S; Serru V; Sales JP; Wind P; Cugnenc PH; Vaubourdolle M; Loric S
Clin Chem Lab Med; 2005; 43(2):127-32. PubMed ID: 15843204
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
[TBL] [Abstract][Full Text] [Related]
9. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients.
Xu D; Li XF; Zheng S; Jiang WZ
J Zhejiang Univ Sci B; 2006 Jun; 7(6):445-51. PubMed ID: 16691638
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.
Sahengbieke S; Wang J; Li X; Wang Y; Lai M; Wu J
J Clin Lab Anal; 2018 May; 32(4):e22332. PubMed ID: 28948632
[TBL] [Abstract][Full Text] [Related]
11. Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA.
Funaki NO; Tanaka J; Itami A; Kasamatsu T; Ohshio G; Onodera H; Monden K; Okino T; Imamura M
Life Sci; 1997; 60(9):643-52. PubMed ID: 9048967
[TBL] [Abstract][Full Text] [Related]
12. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
[TBL] [Abstract][Full Text] [Related]
13. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
14. Improved real-time rt-PCR assays of two colorectal cancer peripheral blood mRNA biomarkers: a pilot study.
Yadegarazari R; Hassanzadeh T; Majlesi A; Keshvari A; Monsef Esfahani A; Tootoonchi A; Shabab N; Saidijam M
Iran Biomed J; 2013; 17(1):15-21. PubMed ID: 23279830
[TBL] [Abstract][Full Text] [Related]
15. Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.
Rodia MT; Ugolini G; Mattei G; Montroni I; Zattoni D; Ghignone F; Veronese G; Marisi G; Lauriola M; Strippoli P; Solmi R
Oncotarget; 2016 May; 7(21):30295-306. PubMed ID: 26993598
[TBL] [Abstract][Full Text] [Related]
16. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.
Jonas S; Windeatt S; O-Boateng A; Fordy C; Allen-Mersh TG
Gut; 1996 Nov; 39(5):717-21. PubMed ID: 9014772
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer.
Yu H; Han L; Yuan J; Sun Y
Cancer Biomark; 2020; 27(1):29-37. PubMed ID: 31658042
[TBL] [Abstract][Full Text] [Related]
18. Significance of Plasma
Maeda T; Konishi H; Takaki W; Takabatake K; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Kuriu Y; Otsuji E
Anticancer Res; 2021 Apr; 41(4):1761-1769. PubMed ID: 33813380
[TBL] [Abstract][Full Text] [Related]
19. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
[TBL] [Abstract][Full Text] [Related]
20. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.
Wong IH; Yeo W; Chan AT; Johnson PJ
Cancer Lett; 2001 Jan; 162(1):65-73. PubMed ID: 11121864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
